Karel Kostev to Glycated Hemoglobin A
This is a "connection" page, showing publications Karel Kostev has written about Glycated Hemoglobin A.
Connection Strength
1.802
-
Association of characteristics of people with type 2 diabetes mellitus with discordant values of fasting glucose and HbA1c. J Diabetes. 2018 Dec; 10(12):934-941.
Score: 0.409
-
Low annual frequency of HbA1c testing in people with Type 2 diabetes in primary care practices in Germany. Diabet Med. 2018 02; 35(2):249-254.
Score: 0.391
-
Changes in Glycemic Control and Body Weight After Initiation of Dapagliflozin or Basal Insulin Supported Oral Therapy in Type 2 Diabetes: A Primary Care Database Study. J Diabetes Sci Technol. 2017 05; 11(3):590-596.
Score: 0.366
-
Duration of first prescribed long acting insulin therapy in type 2 diabetes. Diabetes Res Clin Pract. 2012 Jul; 97(1):e3.
Score: 0.261
-
[Effect of the Disease Management Program on HbA1c Value in Type 2 Diabetes Mellitus Patients: A Retrospective Comparison between Disease Management Programs and Standard Care]. Dtsch Med Wochenschr. 2017 Oct; 142(21):e148-e155.
Score: 0.096
-
Prescription Patterns and Disease Control in Type 2 Diabetes Mellitus Patients in Nursing Home and Home Care Settings: A Retrospective Analysis in Germany. J Diabetes Sci Technol. 2018 01; 12(1):136-139.
Score: 0.094
-
Regional differences in insulin therapy regimens in five European countries?. Int J Clin Pharmacol Ther. 2017 May; 55(5):403-408.
Score: 0.094
-
Association of dipeptidyl peptidase 4 inhibitors with risk of metastases in patients with type 2 diabetes and breast, prostate or digestive system cancer. J Diabetes Complications. 2017 Apr; 31(4):687-692.
Score: 0.092